title: Detection of cord blood hepcidin levels as a biomarker for early-onset neonatal sepsis.
abstract: Early-onset neonatal sepsis (EONS) continues to be a severe condition associated with a high mortality and morbidity. However, symptoms and laboratory markers of this serious condition are nonspecific and currently there are no available standard tests to provide perfect diagnostic accuracy. An early recognition and initiation of antimicrobial therapy are essential in order to prevent morbidity and mortality. Hepcidin, the key regulator of iron homeostasis, is also an acute-phase reactant, which has a critical role in inflammation and contributes to host defense by interfering with microorganism's access to iron. Since hepcidin expression is induced by interleukin-6 (IL-6), it also plays role in the innate immune system. Recently, endogenous expression of hepcidin by macrophages and neutrophils in response to bacterial pathogens confirmed its role in innate immunity. The clear link between the hepcidin molecule and innate immunity may be used for the detection of EONS. We hypothesized that an increased level of hepcidin in cord blood may be used as a reliable biological marker of EONS and designed a prospective cohort study to test this hypothesis and collected pilot data. Cord blood samples of all infants born between January 2009 and December 2010 at our university hospital were collected after parental consent and a total of 38 infants were enrolled in the study who fulfilled the sepsis criteria. The range of cord blood hepcidin was found to be significantly increased in newborns with EONS (min-max: 118.1-8400 ng/mL). To the best of our knowledge, this is the first study to investigate the pathophysiologic relevance of hepcidin in EONS and demonstrate increased levels of hepcidin in cord blood as an acute-phase reactant in response to sepsis.
authors.affiliation: Fatih University Medical School, Department of Pediatrics, Division of Neonatology, Turkey. Electronic address: nevzatcizmeci@gmail.com.
authors.forename: Mehmet Nevzat
authors.initials: MN
authors.lastname: Cizmeci
authors.affiliation: Fatih University Medical School, Department of Pediatrics, Division of Neonatology, Turkey.
authors.forename: Semra
authors.initials: S
authors.lastname: Kara
authors.affiliation: Fatih University Medical School, Department of Pediatrics, Division of Neonatology, Turkey.
authors.forename: Mehmet Kenan
authors.initials: MK
authors.lastname: Kanburoglu
authors.affiliation: Fatih University Medical School, Department of Obstetrics and Gynecology, Turkey.
authors.forename: Serap
authors.initials: S
authors.lastname: Simavli
authors.affiliation: Fatih University Medical School, Department of Obstetrics and Gynecology, Turkey.
authors.forename: Candan Iltemur
authors.initials: CI
authors.lastname: Duvan
authors.affiliation: Fatih University Medical School, Department of Pediatrics, Division of Neonatology, Turkey.
authors.forename: Mustafa Mansur
authors.initials: MM
authors.lastname: Tatli
mesh_terms: D015415:Biomarkers / Q000097:blood*; D005312:Fetal Blood / Q000737:chemistry*; D064451:Hepcidins / Q000097:blood*; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000097:blood*; D018805:Sepsis / Q000097:blood*
chemical_list: D015415:Biomarkers; D064451:Hepcidins